JavaScript is currently not supported/disabled by this browser. Please enable JavaScript for full functionality.

Call Us 1 - 866 - 986 - 9598
orders@biohippo.com

Sign Up

Login
- My Order
- Return Requests
- Track my Order

Home / Primary Antibodies / Polyclonal Antibodies

BAGE4 antibody

SKU : BHA10800785

Contact us to order

Tel

+1 866.986.9598

Email

orders@biohippo.com

Get a Quote

Request More Infos

Fine Test

view supplier details

Order Now

Credit card payments now incur a 3% fee.

Contact us to order

Tel

+1 866.986.9598

Email

orders@biohippo.com

Get a Quote

Ask Merchant

Request More Infos

Sample Request

Mfr.No.	FNab00790
Alternative Names	MLL3P
Background	BAGE4, also named as MLL3P and CT2.4, belongs to the BAGE family. It is a candidate gene encoding tumor antigens. BAGE4 is Cancer/testis antigen 2.4. The antibody can recognize BAGE4, BAGE, BAGE3, BAGE5.
Categories	Primary Antibodies
Clonality	polyclonal
Description	Unknown. Candidate gene encoding tumor antigens.
Host	Rabbit
Immunogen	B melanoma antigen family, member 4
Isotype	IgG
Reactivity	Human
Regulatory	RUO
Synonyms	B melanoma antigen 4, BAGE4, Cancer/testis antigen 2.4, CT2.4, MLL3P

Uniprot	Q86Y28
Gene Id	85317
Research Area	Cancer

Form	liquid
Format	liquid
Purification	Immunogen affinity purified
Purity	>=95% as determined by SDS-PAGE
Storage	PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months(Avoid repeated freeze / thaw cycles.)

Applications	ELISA, IHC
Description	ELISA ; IHC
Tested Application	IHC: 1:20-1:200

Manual	FNab00790.pdf

Have you used this product?

Rate it now..!!

Login to Review

SKU	Supplier No.	Size	Your price	Quantity
BHA10800785	FNab00790	100ug	$240		Add to Cart

ebiohippo.com provides biomedical researchers with a one-stop informatic shopping experience by transforming biotechnology products’ data into a ready-to-analyze state. We collect and unify suppliers’ data on a single platform to reduce the time of searching, uncertainty, and cost of scientific experiments.

© 2025 Biohippo. All rights reserved.